China Molybdenum Co (3993) AI Stock Analysis

• Market Cap: $243.73B
• Dividend Yield: 2.54%
• Average Volume (3M): 47.47M
• Price to Earnings (P/E): 13.5
• Beta (1Y): 1.19
• Revenue Growth: 12.14%
• EPS Growth: 53.33%
• Country: HK
• Employees: 12,317
• Sector: Basic Materials
• Sector Strength: 60
• Industry: Industrial Materials
• EPS (TTM): 0.20
• Shares Outstanding: 3,933,468,000
• 10 Day Avg. Volume: 42,620,034
• 30 Day Avg. Volume: 47,467,638
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.60
• Enterprise Value/Revenue: 0.69
• Enterprise Value/Gross Profit: 4.16
• Enterprise Value/Ebitda: 5.30
• 1Y Price Target: $8.94
• Price Target Upside: -18.35% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 3

• Rating: 72 Outperform
• Price Target: HK$10.00 ▼(-8.68% Downside)

The stock scores well due to strong financial performance, marked by impressive revenue and profit growth, efficient capital management, and robust cash flow generation. Technical analysis indicates strong momentum but highlights an overbought condition, suggesting caution. The valuation is reasonable, albeit with a low dividend yield, making it less attractive for income investors. The absence of earnings call and corporate events does not impact the score calculation.

Positive Factors

Earnings

CMOC announced preliminary net profits of Rmb12.8-Rmb14.2bn in 2024, up 55-72% YoY.

Expansion Strategy

Earnings growth supported by stronger sales volume in DRC and expansion towards EV battery materials.

Sales Volume

CMOC attributed the strong performance to much higher copper and cobalt sales volume, higher copper prices, and efforts to lower production costs.

Negative Factors

Production Guidance

2025 Production Guidance is roughly flat YoY: Planned copper production ranges from 600 to 660kt, vs. 650kt actual production in 2024.

China Molybdenum Co Business Overview & Revenue Model

Company Description

CMOC Group Limited, together with its subsidiaries, engages in the mining, beneficiation, smelting, refining, and trading of copper, cobalt, molybdenum, tungsten, niobium, phosphates, and other base and rare metals. The company provides molybdenum oxide, ferromolybdenum, molybdenum and tungsten concentrates, copper concentrate, cobalt hydroxide, ferroniobium, phosphate fertilizer, gold and silver, and other related products. It is also involved in the refining and sale of mineral products; purchase and sale of molybdenum and tungsten products; import and export of goods and technology; and hotel management, consulting, enterprise operating and management, asset management, logistics, and transportation businesses. It has operations in China, Australia, Brazil and the Democratic Republic of the Congo, Switzerland, and internationally. China Molybdenum Co., Ltd. was incorporated in 2006 and is based in Luoyang, the People's Republic of China.

How the Company Makes Money

China Molybdenum Co. makes money primarily through the mining, processing, and sale of non-ferrous metals, including molybdenum, tungsten, copper, and cobalt. The company operates mines and production facilities in China, the Democratic Republic of Congo, Brazil, and Australia, allowing it to leverage a broad geographic footprint. Revenue is generated by extracting these metals and selling them to industries that require them for manufacturing products such as steel alloys, electronics, batteries, and industrial machinery. Additionally, CMOC's involvement in trading activities contributes to its revenue streams by facilitating the distribution and sale of its mineral products globally. Strategic partnerships and joint ventures with other mining companies and stakeholders further enhance its market position and profitability by optimizing resource extraction and distribution channels.

China Molybdenum Co Financial Statement Overview

Summary

China Molybdenum Co demonstrates strong financial health with robust revenue and profit growth. The company maintains an efficient balance sheet with reduced leverage and strong equity returns. Cash flow generation is impressive, ensuring liquidity and financial stability. Overall, the financial position is strong with positive growth trajectories and efficient capital management.

Income Statement

The company shows strong revenue growth with a 14.36% increase from the previous year. Gross profit margin improved significantly to 16.55%, indicating effective cost management. Net profit margin is at 6.35%, showing a healthy bottom line. EBIT and EBITDA margins are robust at 11.86% and 14.73%, respectively, reflecting operational efficiency.

Balance Sheet

The debt-to-equity ratio decreased to 0.42, indicating improved leverage management. Return on equity is strong at 19.06%, suggesting effective use of equity capital. The equity ratio at 41.72% reflects a balanced capital structure. The reduction in total liabilities also strengthens the balance sheet.

Cash Flow

Operating cash flow increased significantly, enhancing liquidity. Free cash flow saw substantial growth, supporting financial flexibility. The operating cash flow to net income ratio is strong at 2.39, indicating robust cash-generating ability from operations. Free cash flow to net income ratio at 2.03 further underscores efficient cash conversion.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	213.03B	186.27B	172.99B	173.86B	112.98B
Gross Profit	35.25B	17.83B	16.06B	16.32B	8.45B
EBITDA	31.39B	20.17B	17.10B	10.56B	9.01B
Net Income	13.53B	8.25B	6.07B	5.11B	2.33B
Balance Sheet
Total Assets	170.24B	172.97B	165.02B	137.45B	122.44B
Cash, Cash Equivalents and Short-Term Investments	36.94B	39.00B	36.88B	31.44B	24.38B
Total Debt	29.64B	50.86B	48.35B	46.86B	45.03B
Total Liabilities	84.29B	101.01B	102.98B	89.19B	75.11B
Stockholders Equity	71.02B	59.54B	51.70B	39.85B	38.89B
Cash Flow
Free Cash Flow	27.49B	2.62B	4.94B	1.91B	870.66M
Operating Cash Flow	32.39B	15.54B	15.45B	6.19B	8.49B
Investing Cash Flow	-1.16B	-10.66B	―	―	―
Financing Cash Flow	-30.57B	-8.61B	―	7.89B	422.30M

China Molybdenum Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.95
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3993, the sentiment is Positive. The current price of 10.95 is above the 20-day moving average (MA) of 9.56, above the 50-day MA of 8.33, and above the 200-day MA of 6.40, indicating a bullish trend. The MACD of 0.65 indicates Negative momentum. The RSI at 79.61 is Negative, neither overbought nor oversold. The STOCH value of 93.62 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3993.

China Molybdenum Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3993	72 Outperform	$243.73B	13.50	22.95%	2.54%	12.14%	53.33%
Sector *	61 Neutral	$10.09B	5.98	1.14%	3.01%	3.01%	-45.09%
CTJHF	―	$416.77M	8.16	7.21%	4.36%	―	―
00D0	―	€199.82M	―	-26.13%	―	―	―
2245	78 Outperform	HK$24.24B	12.24	17.83%	2.44%	36.51%	66.77%
3939	76 Outperform	HK$38.30B	49.64	25.55%	0.90%	40.22%	46.48%
9696	58 Neutral	HK$76.54B	―	-8.74%	3.37%	-59.41%	-169.49%

China Molybdenum Co Corporate Events

CMOC Group Limited Announces Interim Results Briefing Session

CMOC Group Limited has announced a briefing session to discuss its interim results for the first half of 2025. The session, scheduled for August 25, 2025, will be conducted online via the SSE Roadshow platform, allowing investors to engage with the company’s management and independent directors. This initiative aims to enhance transparency and provide stakeholders with insights into the company’s performance and future prospects.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

CMOC Group Limited Announces Upcoming Board Meeting for Interim Results

CMOC Group Limited has announced a board meeting scheduled for August 22, 2025, to discuss and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant for stakeholders as it will provide insights into the company’s performance and strategic direction for the upcoming months.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

CMOC Group Limited Announces Significant Profit Increase for H1 2025

CMOC Group Limited has announced a positive profit alert for the first half of 2025, with an estimated net profit increase of 51.37% to 67.98% compared to the same period last year. This growth is attributed to higher selling prices and increased output of copper and cobalt, highlighting the company’s improved economies of scale and market positioning.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

CMOC Group Limited Announces Key Changes Following Annual and Class Meetings

CMOC Group Limited held its 2024 annual general meeting and the 2025 first class meetings for A and H shareholders on May 30, 2025. Key outcomes included the approval of the payment of a final dividend, the appointment of new executive directors, the resignation of a non-executive director and chairman of the board, and a change in the authorized representative. These developments are expected to impact the company’s governance structure and potentially influence its strategic direction.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

China Molybdenum Co Announces Leadership and Structural Changes

China Molybdenum Co has announced significant leadership and structural changes, including the appointment of Liu Jianfeng as the new chairman of the board. The company has also made adjustments to the composition of its board committees, which may impact its strategic direction and governance. These changes are part of a broader effort to optimize the company’s management and investment strategies, potentially influencing its market position and stakeholder relations.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

CMOC Group Limited Announces Final Dividend for 2024

China Molybdenum Co, operating under CMOC Group Limited, announced a final ordinary cash dividend of RMB 2.55 per 10 shares for the financial year ending December 31, 2024. The dividend, approved on May 30, 2025, will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.08991, with a payment date set for July 18, 2025. The announcement includes details on withholding tax rates applicable to different shareholder categories, impacting non-resident enterprises and individual investors in mainland China.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

CMOC Group Limited Announces Board Composition and Roles

CMOC Group Limited has announced the composition of its board of directors and their roles within the company. The board includes executive, non-executive, and independent non-executive directors, with specific members serving on various committees such as the Audit and Risk Committee, Nomination and Governance Committee, Remuneration Committee, and Strategic and Sustainability Committee. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic direction and stakeholder confidence.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

China Molybdenum Co. Completes Payment on 2020 Medium-Term Notes

China Molybdenum Co., Ltd. announced the successful completion of payment for its 2020 first tranche medium-term notes, which were issued on May 28, 2020, with a total amount of RMB1 billion, a coupon rate of 4.20%, and a term of five years. This completion marks a significant financial milestone for the company, reinforcing its financial stability and commitment to fulfilling its financial obligations, which could positively impact its reputation and stakeholder confidence.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.